Generic versions of off-patent drugs, which today account for more than 88% of all prescriptions, save patients and the U.S. healthcare system hundreds of billions of dollars per year. That isn't turning out to be the case with biosimilars.
Last week, research on several fronts, timed for release during the annual American Heart Association meeting, raised serious questions about how the nation spends about $200 billion each year on cardiac care.
Last week's election results in Kentucky and Virginia dashed any hope that attacks on Obamacare might finally be losing their political currency. Healthcare providers and payers should brace themselves for a full year of well-funded assaults on the law.
While HealthCare.gov 3.0, the online portal offering health insurance options for 37 states and the District of Columbia, is vastly improved over last year's cumbersome model, it still has a long way to go.
Recent history has proved poorly designed payment reforms have unintended and unwanted consequences. The CMS is on the cusp of making that mistake with its plan to bundle payments for replacing knees and hips.
Open enrollment on the Affordable Care Act insurance exchanges starts in less than two weeks. Coverage expansion supporters are worried about whether the exchanges will succeed in luring a large number of new enrollees for 2016.
As the campaign season heats up, opposition to the so-called Cadillac tax on high-cost health insurance plans is growing. Congress should reject any attempt at outright repeal.
Training in 21st century medicine must be aimed at creating health team leaders. They must be able to work closely with other professionals, understand population health and health policy, and know how to work within the social and economic constraints now reshaping their industry.
Despite its title, “Improving Diagnosis in Health Care,” you have to dig deep into the Institute of Medicine's first-ever report on the problem of misdiagnosed patients to find proposals that will have an immediate impact on the problem.
With President Barack Obama pushing his Precision Medicine Initiative, and a slew of new genetic diagnostic tests entering the market, it's worth revisiting the recent payment history for PET scans, the go-go imaging technology whose use exploded in the early 2000s.
Congress is back in session. The fact-free political campaign season lies ahead. What better time to offer a special themed edition of Modern Healthcare's Data Points feature as background for an issue dominating the headlines?
Over the several years that the CMS and hospitals have been tussling over the reasons behind the steady rise in short-term observation stays, no one until now has suggested the increase represents a deliberate effort by hospitals to avoid Medicare's 30-day readmission penalties.